Celebrating the 10th Annual

Canadian Hematology Conference 2020

Thank you for attending CHC!

Clinicial Presentations

 Click on the presentation title to access clinical slide decks 

Plasma Cell Dyscrasias 

New Developments in Amyloidosis 
Dr. Chris Venner – Cross Cancer Institute

Myeloma 2020 and Beyond 
Dr. Keith Stewart – Princess Margaret Cancer Centre

Treatment of Relapsed Refractory Multiple Myeloma in the Canadian Landscape
Dr. Kevin Song – BC Cancer

Chronic Lymphocytic Leukemia

Where Are We Headed in CLL?
Dr. Michael Hallek – Universität zu Köln (Cologne, Germany)

Front Line Management of CLL
Dr. Graeme Fraser – Juravinski Cancer Centre

Relapse CLL in 2020
Dr. Carolyn Owen – University of Calgary


The Challenges Ahead: A Translational Science Perspective on Immunotherapy 
Rob Laister, Translational Scientist, PhD – Princess Margaret Cancer Centre

Cell Therapy
Dr. Ronan Foley – Juravinski Cancer Centre

Antibody-Based Immunotherapy
Dr. John Kuruvilla – Princess Margaret Cancer Centre

Non-Hodgkin Lymphoma I

Axicabtagene Ciloleucel in DLBCL: Determinants of Efficacy 
Dr. Frederick Locke – Moffitt Cancer Center (Florida, USA)

Relapsed Follicular Lymphoma: A Therapeutic Challenge
Dr. Michael Crump – Princess Margaret Cancer Centre

The Use of RT in NHL in Canada: Evolving Paradigms
Dr. Richard Tsang – Princess Margaret Cancer Centre

Acute Leukemia, MDS, & MPNs

AML in 2020: Evolving Therapeutics that are Changing Therapy
Dr. Eunice Wang – Roswell Park Comprehensive Cancer Center (New York, USA)

New Developments in MDS Diagnosis, Prognosis, and Therapy 
Dr. Rena Buckstein – Odette Cancer Centre

Reviewing MPNs in 2020: A Practical and Therapeutic Approach
Dr. Vikas Gupta – Princess Margaret Cancer Centre

Translational Science

Towards Biology – Informed Management of B-Cell Lymphoma
Dr. Robert Kridel – Princess Margaret Cancer Centre

Immunoprofiling for the Clinician: Lessons from Cell Therapy
Dr. Marcus Butler – Princess Margaret Cancer Centre

Non-Hodgkin Lymphoma II

Mantle Cell Lymphoma: Current Standards and Future Perspectives 
Dr. Martin Dreyling – LMU Hospital (Munich, Germany)

Current Management Approaches to Patients with Non-MALT Marginal Zone Lymphoma
Dre Catherine Thieblemont – Hôpital Saint-Louis (Paris, France)

Treatment Landscape of Waldenström Macroglobulinemia
Dr. Steve Treon – Dana-Farber Cancer Institute (Massachusetts, USA)

Marginal Zone Lymphoma
Dr. Emanuele Zucca – Oncology Institute of Southern Switzerland (Bellinzona, Switzerland)

PET-Pearls and PET-Falls: The Role in Follicular Lymphoma
Dr. Judith Trotman – Concord Repatriation General Hospital (Sydney, Australia)

Hodgkin Lymphoma

Limited Stage Hodgkin’s Lymphoma in 2020: A Practical Approach Based on Today’s Data 
Dr. Martin Hutchings – Rigshospitalet (Copenhagen, Denmark)

Advanced Hodgkin’s Lymphoma in 2020: A Practical Approach Based on Today’s Data
Dr. Jonathan Friedberg – Wilmot Cancer Institute (New York, USA)

How we treat R/R-cHL in Canada in 2020
Dr. John Kuruvilla – Princess Margaret Cancer Centre

Radiation Therapy in Hodgkin Lymphoma 2020: Balancing Risks
Dr. David Hodgson – Princess Margaret Cancer Centre

About CHC 2020

CHC is the largest multi-disciplinary hematological conference across Canada. It brings together a pan-Canadian and International Faculty to showcase cutting-edge research and developments in the field of hematology. This meeting covers a breadth of topics, including (but not limited to): Plasma Cell Dyscrasias, Non-Hodgkin’s Lymphoma, Hodgkin’s Disease, Chronic Lymphocytic Leukemia, Immunotherapy, Translational Science, Leukemia & MDs.

Dr. John Kuruvilla (Princess Margaret Cancer Centre) and Dr. Peter Anglin (Stronach Regional Cancer Centre) will co-chair this event. CHC 2020 is open to Canadian hematology professionals, including residents, nurses, pharmacists, and specialists who have an interest in hematology.

Thank You to our Sponsors!